Statistics for Combination treatment with EGFR inhibitor and doxorubicin synergistically inhibits proliferation of MCF-7 cells and MDA-MB-231 triple-negative breast cancer cells In Vitro

Total visits

views
Combination treatment with EGFR inhibitor and doxorubicin synergistically inhibits proliferation of MCF-7 cells and MDA-MB-231 triple-negative breast cancer cells In Vitro 6

Total visits per month

views
October 2023 0
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 6
April 2024 0

File Visits

views
Abrahams_Combination treatment with EGFR inhibitor_2024.pdf 12

Top country views

views
South Africa 6

Top city views

views
Bloemfontein 4